Raaj Medisafe India Ltd.

55.93 +2.66 ▲5.0%

06 May 2024, 04:01:00 PM
Volume: 300

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Industry Icon Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.raajmedisafeindia.com
Market Cap 73.90 Cr.
Enterprise Value(EV) 89.85 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.42 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 23.14 Trailing Twelve Months Ending 2023-12
Industry PE 59.32 Trailing Twelve Months Ending 2023-12
Book Value / Share 9.29 Trailing Twelve Months Ending 2023-12
Price to Book Value 6.02 Calculated using Price: 55.93
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.32 Cr. 13,212,612 Shares
FaceValue 10
About Raaj Medisafe India Ltd.
The company deals in wide range of personal and hospital hygiene related products like disposable bed sheets, pillow covers, stretcher sheets, under pads, sanitary napkins, panty liners, baby diapers & adult diapers, etc.

Raaj Medisafe India Ltd. Delivery

Delivered Qty
Traded Qty

Raaj Medisafe India Ltd. Performance

1 Day
+4.99%
1 Week
+9.67%
1 Month
+10.80%
3 Month
+9.58%
6 Month
+34.77%
1 Year
+43.71%
2 Year
+41.77%
5 Year
+439.34%
10 Year

Raaj Medisafe India Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 0 0 0 0 0 0 115.41 57.21
Return on Capital Employed (%) -24.25 -13.98 -8.33 -21 -24.82 16.3 27.03 28.33 24.24
Return on Assets (%) -33.33 -22.4 -15.08 -26.04 -30.95 -3.09 15.23 16.63 14.67

Raaj Medisafe India Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -3 -4 -5 -6 -8 -1 1 4 7 9
Non Curr. Liab. 7 7 8 8 10 8 9 6 7 6
Curr. Liab. 0 2 3 3 3 7 7 10 11 12
Minority Int.
Equity & Liab. 4 5 6 5 5 14 17 20 26 28
Non Curr. Assets 3 4 4 3 3 7 9 10 11 11
Curr. Assets 1 2 2 2 2 6 7 10 15 17
Misc. Exp. not W/O
Total Assets 4 5 6 5 5 14 17 20 26 28

Raaj Medisafe India Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 2 4 4 5 22 32 35 39 42
Other Income 0 0 0 0 0 0 0 0 0
Total Income 0 2 4 4 5 22 32 35 39 42
Total Expenditure -1 -2 -4 -4 -6 -20 -28 -30 -33 -36
PBIDT -1 0 0 0 -1 2 4 5 6 6
Interest 0 -1 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation 0 0 0 0 0 -1 -1 -1 -1 -1
Taxation 0 0 -1 0 0
Exceptional Items 0 0 0 0 0 0 0
PAT -1 -1 -1 -1 -2 0 2 3 3 3
Adjusted EPS -2 -2 -2 -3 -3 -1 2 3 3 3

Raaj Medisafe India Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 0 0 0 0 -1 -1 2 2 0
Cash Fr. Inv. 0 -2 -1 -1 0 0 0 -3 -1 -2
Cash Fr. Finan. 1 3 0 1 0 1 1 1 -1 1
Net Change 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Raaj Medisafe India Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 73.45 73.45 73.45 73.45 73.45 73.45 73.45 73.45 73.45
Public 26.55 26.55 26.55 26.55 26.55 26.55 26.55 26.55 26.55
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Raaj Medisafe India Ltd. Announcements

Mon, 06 May 2024
Board Meeting Outcome for Allotment Of 2275000 Equity Shares Of Rs. 10 Each At A Premium Of Rs.34 Per Share On Preferential Basis.
Boar of Directors in its meeting held on today i.e. May 6 2024 has approved the allotment of 2275000 Equity Shares of Rs. 10 each at a premium of Rs.34.00 Per share on Preferential Basis as per details given in the letter attached herewith.
Fri, 03 May 2024
Board Meeting Intimation for Board Meeting Is Scheduled To Be Held On Monday May 06 2024 At 11.00 AM For Allotment Of Equity Shares
RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 inter alia to consider and approve Board Meeting is scheduled to be held on Monday May 06 2024 at 11.00 AM for Allotment of Equity Shares inter alia to consider and to approve allotment of 227500 Fully paid up equity Shares of Rs. 10 Each at a premium of Rs.34 per share
Mon, 22 Apr 2024
Compliances : Certificate Under Regulation 40(9) For The Year Ended March 31 2024
We attach herewith Certificate under Regulation 40 (9) of the SEBI (LODR) Regulations 2015 for the year ended March 31 2024.

Raaj Medisafe India Ltd. Technical Scans

Mon, 06 May 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Opening at Low for 3 days Opening at Low for 3 days
Closing Above Previous High Closing Above Previous High

Raaj Medisafe India Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 367,026.27 1,529.55 +1.4%
Cipla Ltd. 114,924.60 1,423.40 -0.1%
Divi's Laboratories Ltd. 105,128.21 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. 105,108.85 6,293.45 -0.9%
Zydus Lifesciences Ltd. 102,736.49 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. 91,906.55 2,720.45 -0.4%
Mankind Pharma Ltd. 91,490.39 2,286.05 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.21 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-12 30.99 1,423.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 76.02 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.10 6,293.45 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.55 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 61.52 2,720.45 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 52.97 2,286.05 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.88 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-12 4.44 1,423.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 8.07 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.91 6,293.45 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.45 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.85 2,720.45 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.30 2,286.05 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,423.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,293.45 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,720.45 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,286.05 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,423.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,293.45 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,720.45 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,286.05 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,423.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,293.45 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,720.45 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,286.05 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,423.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,293.45 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,720.45 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,286.05 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,529.55 +1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,423.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,958.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,293.45 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,020.75 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,720.45 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,286.05 -1.2%

Raaj Medisafe India Ltd. FAQ's

What is Raaj Medisafe India share price?

Can I buy Raaj Medisafe India shares now?

What is the Market Cap of Raaj Medisafe India?

What are the key metrics to analyse Raaj Medisafe India?

What is the 52 Week High and Low of Raaj Medisafe India?

What is the trend of Raaj Medisafe India share price?